Subject: My view on Rule S7-2026-15
From: Deb Gavin
Affiliation:

Jun. 19, 2026

To the Securities and Exchange Commission:sincee PharmDs are mainstream, no one, except people in Healthcare for many years, realize their info is everywhere including international, course that's why musk multyplying.